Cardiac Surgery Devices Market Outlook (2022 to 2032)
The global cardiac surgery devices market is expected to enjoy a valuation of US$ 1.7 Billion by the end of 2022 and further expand at a CAGR of 3.6% during the forecast period (2022 to 2032). Sales in the market are expected to reach a valuation of ~US$ 2.4 Billion by 2032 on the back of the rising prevalence of cardiovascular diseases. In terms of product type, the perfusion disposables led the market with a demand share of about 59.1%% in 2021.
Cardiac surgery devices are devices used during an open heart procedure to repair structural defects in the cardiovascular system, such as coronary artery bypass grafting, congenital heart defects, abdominal aortic aneurysm repair, ventricular remodeling, and implantation of cardiac assist devices. Devices such as heart-lung machines are used during cardiothoracic surgery and are most commonly used to perform a cardiopulmonary bypass.
Attributes
Key Insights
Cardiac Surgery Devices Market Value 2021
US$ 1.6 Billion
Estimated Market Size 2022
US$ 1.7 Billion
Projected Market Value 2032
US$ 2.4 Billion
CAGR 2022 to 2032
3.6%
Market Share of Top 5 Countries
57.6%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales Analysis of Cardiac Surgery Devices from 2012 to 2021 Vs Demand Outlook for 2022 to 2032
As per Future Market Insights (FMI), the demand in the global cardiac surgery devices market grew at a CAGR of 3.2% from 2012 to 2021. Sales in the market are poised to expand owing to the rising demand for coronary artery treatment and rising technological advancements in the healthcare industry.
The cardiac surgery devices market was approximately 1% of the global medical device market valued at US$ 457 Billion in 2021. Devices for cardiac surgery are being developed as per patients' needs and on the back of technological advancements in the industry. Hence, key players in the cardiac surgery devices market are launching cutting-edge technologies and designs to strengthen their position in the industry.
Furthermore, there is an increased demand for cardiac surgical equipment due to the rising incidence of cardiovascular diseases, especially among the older population. For instance, it is anticipated that by 2060, 98 million Americans aged 65 and older will be more than a fourfold increase from the current 46 million. The World Health Organization (WHO) report states that cardiovascular disease is the top cause of death worldwide. About 17.9 million deaths globally in 2019 were attributed to cardiovascular illnesses, i.e., 32% of all fatalities.
Further, demand for effective cardiac surgery devices, accessories, and surgical procedures will be fuelled as leading healthcare companies are expanding their cardiovascular devices product portfolio. These companies are also likely to form alliances and acquire companies to generate efficient product advancements that are safe and effective. On the back of these aforementioned factors, the global cardiac surgery devices market is expected to grow at a CAGR of 3.6% during the forecast period from 2022 to 2032.
What are the Key Opportunities for the Cardiac Surgery Device Manufacturers?
Favorable Government Investments and Product Launches to be the Key Strategy for Growth
Government authorities in developing countries have been promoting start-up businesses and MNCs to help the healthcare and medical device industries grow commercially. To strengthen their position, leading firms in the medical device industry are collaborating with the government. Hence, with increasing government funding and initiatives in countries such as India, China, and Japan, the cardiac surgery devices market is expected to flourish over the upcoming decade.
Furthermore, the increasing prevalence of chronic diseases and rising traumatic injuries in developing economies is expected to propel growth over the forecast period. Moreover, manufacturers are consistently improving their product portfolio by developing novel and efficient products. Hence, the advent of technologically advanced devices and increased product launches will drive the cardiac surgery devices market.
Find your sweet spots for generating winning opportunities in this market.
Which are the Factors Restraining Demand for Cardiac Surgery Devices?
Stringent Regulations and High Cost of Cardiac Surgery Devices to Impede the Growth
The demand for cardiac surgery devices is likely to be restrained due to high pricing and cost-cutting for cardiac surgery device manufacturers. The pricing pressure due to government regulations and competitive pricing on healthcare device manufacturers might create challenges for incumbents and start-ups in developing economies.
Moreover, the cardiac surgery devices market can be negatively affected due to strict and extended approval processes by regulatory authorities such as the FDA and others. Cardiac surgery instruments such as heart-lung machines and heat exchangers are known as class II medical equipment in the USA. FDA.
Therefore, these instruments undergo a special test for their compatibility, performance, sterility, and shelf life. Thus, these devices need to obtain regulatory approval, which is an expensive and lengthy process. This is expected to impede the overall growth in the cardiac surgery devices market.
Country-wise Insights
How will Demand in the USA Cardiac Surgery Devices Market Surge?
Rising Cases of Obesity and Cardiovascular Diseases to Boost the Sales
The USA dominated the North American cardiac surgery devices market with a total share of about 86.2% in 2021. Demand in the market is predicted to rise on the back of rising cardiovascular diseases in the country. With the growing prevalence of obesity in the USA a significant share of the population suffers from cardiovascular diseases.
Among these, a considerable percentage of the population undergoes cardiac surgery, as per the study. Backed by this, the demand for advanced cardiac surgery devices is expected to increase over the forecast period.
Additionally, another key factor such as rising healthcare costs is contributing to the USA. cardiac surgery devices market. For instance, in the USA heart disease is the leading cause of death for both genders and for individuals of the majority of racial and ethnic groups. The deaths caused by heart disorders were almost 697,000 people in 2020, according to the report by the Centers for Disease Control and Prevention.
What is the Outlook for India in the Cardiac Surgery Devices Market?
Cost-Effective Treatment Rates in India to Propel Cardiac Surgery Devices Sales
India is set to exhibit growth at a CAGR of nearly 2.7% in the South Asia cardiac surgery devices market during the forecast period. An increasing number of patients undergoing cardiac surgeries is expected to positively affect sales in India. Due to the rising incidence of cardiac conditions, treatment rates are also surging. This is expected to improve the growth in the cardiac surgery devices market.
As per the study in BMJ Journals, approximately 60,000 open heart surgeries are performed annually in India. Therefore, the increasing number of heart bypass surgeries, heart valve surgeries, and heart transplant surgeries are propelling the market for cardiac surgery devices in India.
In India, the cost of surgeries and treatments is comparatively less than in other countries like USA and Europe. Thus, the increasing popularity of medical tourism in India is propelling growth in the market.
Will Germany Emerge as a Lucrative Cardiac Surgery Devices Market?
Growing Medical Tourism in Germany to Aid the Growth in Cardiac Surgery Devices Market
Germany held approximatelya 4.1% share in the global cardiac surgery devices market in 2021 and is projected to display a growth rate of 4.9 % during the forecast period.
The developing healthcare infrastructure and increasing medical tourism in Germany are the key factors propelling the demand for cardiac surgery devices. Germany is one of the countries leading the medical tourism field due to the high international standards and technological advancements such as robotic surgery.
Further, hospitals in Germany are adopting high-quality medical equipment to treat different heart surgeries. Therefore, the technological advancements in cardiac surgery devices are driving growth in Germany.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which Type of Product is Gaining Traction in Cardiac Surgery Devices Market?
Over 3/5th of Cardiac Surgery Devices, Sales are to be Contributed by Perfusion Disposables
In terms of product type, perfusion disposables held a share of approximately 59.1% in 2021. Growth in the segment is expected to surge as cases of valvular degeneration in the geriatric population rise. Additionally, the extensively developed healthcare industry and advancements in cardiac surgery devices are also accelerating the growth in the segment.
Which Type of Procedure will Generate the Maximum Profit in Cardiac Surgery Devices Market?
Rising Incidence of Coronary Heart Diseases to Propel the Adoption in the Market
Based on the procedure, the coronary artery bypass grafting segment accounted for 61.6% of the sales in the global cardiac surgery devices market. The frequency of cardiovascular conditions like coronary heart disease (CHD), peripheral vascular disease, etc. is increasing globally. Hence, the use of coronary artery bypass grafting surgical procedures is expected to surge to treat cardiovascular disorders.
Which is the Leading End User in the Cardiac Surgery Devices Market?
In terms of end users, the hospital's segment held the highest market share of around 60.1% in 2021. In hospitals, the adoption of cardiac treatment and surgeries is benefiting the market growth. The hospitals are improving the quality of treatment and customer service with cost reduction. The hospitals are ahead of the curve in identifying favorable avenues to improve healthcare delivery.
Competitive Landscape
In the cardiac surgery devices market, manufacturers are adopting different strategies to raise their sales and gain revenue. Leading firms are implementing activities like advanced product launches and acquisitions to expand their product portfolio. A few of these strategies undertaken by cardiac surgery devices manufacturers are:
On August 2022, the acquisition of Affera, Inc. has been completed, according to the announcement from Medtronic plc, a pioneer in healthcare technology worldwide. With this acquisition, the company's offering for cardiac ablation is expanded to include its first-ever cardiac mapping and navigation platform, which combines a radiofrequency ablation solution with a targeted pulsed field and distinct diagnostic technology.
On June 2020, the launch of DIRECTSENSE technology was declared by Boston Scientific in the USA It is a tool that is used for monitoring the effect of radiofrequency energy during the process of cardiac ablation.
Report Scope as per Cardiac Surgery Devices Market Analysis
Attribute
Details
Estimated Market Size 2022
US$ 1.7 Billion
Projected Market Value 2032
US$ 2.4 Billion
CAGR 2022 to 2032
3.6%
Forecast Period
2022 to 2032
Historical Data Available for
2012 to 2021
Market Analysis
US$ Million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, and South Africa
Key Market Segments Covered
Product, Procedure, End User, and Region
Key Companies Profiled
Abbott Laboratories
Medtronic Plc.
Boston Scientific Corporation
Lepu Medical Technology Co ltd
LivaNova PLC
Terumo Corporation
Getinge-Maquet Germany Holding GmbH
B. Braun Melsungen AG
C. R. Bard, Inc
Teleflex Incorporated
Angiodynamics
Edwards Lifesciences Corporation
MicroPort Scientific Corporation,
Smith Medical
Abiomed, Inc
Estech
Cook Medical Inc
Braile Biomedica
Biotronik Inc.
Key Market Segments Covered in Cardiac Surgery Devices Market Research
By Product:
Heart Lung Machine
Breathing Heart Surgery Systems
Stabilizers
Positioners
Catheters
Ablation Catheter
Drainage Catheter
Perfusion Disposables
Oxygenators
Centrifugal Pumps
Cardioplegia Delivery System
By Procedure:
Coronary Artery Bypass Grafting
On Pump CABG
Off-Pump CABG
Minimally Invasive Surgery
By End User:
Hospitals
Ambulatory Surgical Centres
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
How much is the cardiac surgery devices market worth in 2021?
The global cardiac surgery devices market is worth US$ 1.6 Billion in 2021.
What is the sales forecast for the cardiac surgery devices market through 2032?
The cardiac surgery devices market is expected to reach US$ 2.Billion Bn by the end of 2032, with sales expected to register a 3.6% CAGR over the forecast period (2022 to 2032).
What are the key trends shaping the cardiac surgery devices industry?
Rising cases of heart diseases, increasing demand for large coronary artery treatment, and strategic collaborations among key players are the key trends shaping the cardiac surgery devices industry.
Which are the top five countries driving demand in cardiac surgery devices market?
The USA., Japan, Canada, China, and Germany are the top five countries driving the demand for cardiac surgery devices.
What is the demand outlook in North America cardiac surgery devices market?
The North American cardiac surgery devices market registered a market share of around 40.2 % in the year 2021.
How will demand in Japan cardiac surgery devices market unfold?
The Japan cardiac surgery devices market is expected to register a growth rate of 2.7% CAGR in the forecast period.
Which countries are the key producers of cardiac surgery devices?
The USA, Japan, and China are the key producers in the cardiac surgery devices market.
How much is the India cardiac surgery devices market worth in 2021?
The India cardiac surgery devices market is worth US$ 56.4 Million in 2021.
What is the outlook of the United Kingdom cardiac surgery devices market?
The United Kingdom cardiac surgery devices market is to grow with a growth rate of 55 over the forecast period.
Table of Content
1. Executive Summary | Cardiac Surgery Devices Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Key Success Factors
4.1. Product Features/ USPs Analysis
4.2. Product Adoption / Usage Analysis
4.3. Key Promotional Strategies, By Key Manufacturers
4.4. Disease Epidemiology
4.5. Regulatory Landscape
4.6. PESTLE Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Medical Device Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Market Consolidation Activities
5.2.3. New Product Launches / Approvals
5.2.4. Increasing Rate of Cardiac Surgery
5.2.5. Availability of Products
5.2.6. Cost of Products
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Procedure
6.1.3. By End User
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product, 2012 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032
8.3.1. Heart Lung Machine
8.3.2. Breathing Heart Surgery Systems
8.3.2.1. Stabilizers
8.3.2.2. Positioners
8.3.3. Catheters
8.3.3.1. Ablation Catheter
8.3.3.2. Drainage Catheter
8.3.4. Perfusion Disposables
8.3.4.1. Oxygenators
8.3.4.2. Centrifugal Pumps
8.3.4.3. Cardioplegia Delivery System
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Procedure
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) By Procedure, 2012 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032
9.3.1. Coronary Artery Bypass Grafting
9.3.1.1. On Pump CABG
9.3.1.2. Off Pump CABG
9.3.2. Minimally Invasive Surgery
9.4. Market Attractiveness Analysis By Procedure
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) By End User, 2012 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. USA
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Procedure
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Procedure
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. USA Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Procedure
12.8.1.2.3. By End User
12.8.2. Canada Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Procedure
12.8.2.2.3. By End User
13. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Procedure
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Procedure
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. Mexico Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Procedure
13.8.1.2.3. By End User
13.8.2. Brazil Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Procedure
13.8.2.2.3. By End User
13.8.3. Argentina Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Procedure
13.8.3.2.3. By End User
14. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. United Kingdom
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Nordic Countries
14.3.1.8. Russia
14.3.1.9. Rest of Europe
14.3.2. By Product
14.3.3. By Procedure
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Procedure
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Procedure
14.8.1.2.3. By End User
14.8.2. Italy Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Procedure
14.8.2.2.3. By End User
14.8.3. France Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Procedure
14.8.3.2.3. By End User
14.8.4. United Kingdom Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Procedure
14.8.4.2.3. By End User
14.8.5. Spain Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Procedure
14.8.5.2.3. By End User
14.8.6. BENELUX Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Procedure
14.8.6.2.3. By End User
14.8.7. Nordic Countries Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Procedure
14.8.7.2.3. By End User
14.8.8. Russia Market Analysis
14.8.8.1. Introduction
14.8.8.2. Market Analysis and Forecast by Market Taxonomy
14.8.8.2.1. By Product
14.8.8.2.2. By Procedure
14.8.8.2.3. By End User
15. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Procedure
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Procedure
15.4.4. By End User
15.5. By End User Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Procedure
15.8.1.2.3. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Procedure
15.8.2.2.3. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Procedure
15.8.3.2.3. By End User
16. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Procedure
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Procedure
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Procedure
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Procedure
16.8.2.2.3. By End User
16.8.3. Malaysia Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Procedure
16.8.3.2.3. By End User
16.8.4. Thailand Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Procedure
16.8.4.2.3. By End User
17. Oceania Market 2012 to 2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Procedure
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Procedure
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. Australia Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Procedure
17.8.1.2.3. By End User
17.8.2. New Zealand Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Procedure
17.8.2.2.3. By End User
18. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of the Middle East and Africa
18.3.2. By Product
18.3.3. By Procedure
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Procedure
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Procedure
18.8.1.2.3. By End User
18.8.2. Turkey Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Procedure
18.8.2.2.3. By End User
18.8.3. South Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Procedure
18.8.3.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players (%)
19.3. Market Presence Analysis
19.3.1. By Regional Footprint of Players
19.3.2. Product Footprint of Players
19.3.3. Channel Footprint of Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Abbott Laboratories
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Key Financials
20.3.1.4. SWOT Analysis
20.3.1.5. Key Developments
20.3.1.6. Sales Footprint
20.3.1.7. Strategy Overview
20.3.1.7.1. Marketing Strategy
20.3.1.7.2. Product Strategy
20.3.1.7.3. Channel Strategy
20.3.2. Medtronic Plc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Key Financials
20.3.2.4. SWOT Analysis
20.3.2.5. Key Developments
20.3.2.6. Sales Footprint
20.3.2.7. Strategy Overview
20.3.2.7.1. Marketing Strategy
20.3.2.7.2. Product Strategy
20.3.2.7.3. Channel Strategy
20.3.3. Boston Scientific Corporation
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Key Financials
20.3.3.4. SWOT Analysis
20.3.3.5. Key Developments
20.3.3.6. Sales Footprint
20.3.3.7. Strategy Overview
20.3.3.7.1. Marketing Strategy
20.3.3.7.2. Product Strategy
20.3.3.7.3. Channel Strategy
20.3.4. Lepu Medical Technology Co ltd
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Key Financials
20.3.4.4. SWOT Analysis
20.3.4.5. Key Developments
20.3.4.6. Sales Footprint
20.3.4.7. Strategy Overview
20.3.4.7.1. Marketing Strategy
20.3.4.7.2. Product Strategy
20.3.4.7.3. Channel Strategy
20.3.5. LivaNova PLC
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Key Financials
20.3.5.4. SWOT Analysis
20.3.5.5. Key Developments
20.3.5.6. Sales Footprint
20.3.5.7. Strategy Overview
20.3.5.7.1. Marketing Strategy
20.3.5.7.2. Product Strategy
20.3.5.7.3. Channel Strategy
20.3.6. Terumo Corporation
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Key Financials
20.3.6.4. SWOT Analysis
20.3.6.5. Key Developments
20.3.6.6. Sales Footprint
20.3.6.7. Strategy Overview
20.3.6.7.1. Marketing Strategy
20.3.6.7.2. Product Strategy
20.3.6.7.3. Channel Strategy
20.3.7. Getinge-Maquet Germany Holding GmbH
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Key Financials
20.3.7.4. SWOT Analysis
20.3.7.5. Key Developments
20.3.7.6. Sales Footprint
20.3.7.7. Strategy Overview
20.3.7.7.1. Marketing Strategy
20.3.7.7.2. Product Strategy
20.3.7.7.3. Channel Strategy
20.3.8. B. Braun Melsungen AG
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Key Financials
20.3.8.4. SWOT Analysis
20.3.8.5. Key Developments
20.3.8.6. Sales Footprint
20.3.8.7. Strategy Overview
20.3.8.7.1. Marketing Strategy
20.3.8.7.2. Product Strategy
20.3.8.7.3. Channel Strategy
20.3.9. C. R. Bard, Inc
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Key Financials
20.3.9.4. SWOT Analysis
20.3.9.5. Key Developments
20.3.9.6. Sales Footprint
20.3.9.7. Strategy Overview
20.3.9.7.1. Marketing Strategy
20.3.9.7.2. Product Strategy
20.3.9.7.3. Channel Strategy
20.3.10. Teleflex Incorporated
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Key Financials
20.3.10.4. SWOT Analysis
20.3.10.5. Key Developments
20.3.10.6. Sales Footprint
20.3.10.7. Strategy Overview
20.3.10.7.1. Marketing Strategy
20.3.10.7.2. Product Strategy
20.3.10.7.3. Channel Strategy
20.3.11. Angiodynamics
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Key Financials
20.3.11.4. SWOT Analysis
20.3.11.5. Key Developments
20.3.11.6. Sales Footprint
20.3.11.7. Strategy Overview
20.3.11.7.1. Marketing Strategy
20.3.11.7.2. Product Strategy
20.3.11.7.3. Channel Strategy
20.3.12. Edwards Lifesciences Corporation
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Key Financials
20.3.12.4. SWOT Analysis
20.3.12.5. Key Developments
20.3.12.6. Sales Footprint
20.3.12.7. Strategy Overview
20.3.12.7.1. Marketing Strategy
20.3.12.7.2. Product Strategy
20.3.12.7.3. Channel Strategy
20.3.13. MicroPort Scientific Corporation
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Key Financials
20.3.13.4. SWOT Analysis
20.3.13.5. Key Developments
20.3.13.6. Sales Footprint
20.3.13.7. Strategy Overview
20.3.13.7.1. Marketing Strategy
20.3.13.7.2. Product Strategy
20.3.13.7.3. Channel Strategy
20.3.14. Smith Medical
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Key Financials
20.3.14.4. SWOT Analysis
20.3.14.5. Key Developments
20.3.14.6. Sales Footprint
20.3.14.7. Strategy Overview
20.3.14.7.1. Marketing Strategy
20.3.14.7.2. Product Strategy
20.3.14.7.3. Channel Strategy
20.3.15. Abiomed, Inc
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Key Financials
20.3.15.4. SWOT Analysis
20.3.15.5. Key Developments
20.3.15.6. Sales Footprint
20.3.15.7. Strategy Overview
20.3.15.7.1. Marketing Strategy
20.3.15.7.2. Product Strategy
20.3.15.7.3. Channel Strategy
20.3.16. Estech
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Key Financials
20.3.16.4. SWOT Analysis
20.3.16.5. Key Developments
20.3.16.6. Sales Footprint
20.3.16.7. Strategy Overview
20.3.16.7.1. Marketing Strategy
20.3.16.7.2. Product Strategy
20.3.16.7.3. Channel Strategy
20.3.17. Cook Medical Inc
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Key Financials
20.3.17.4. SWOT Analysis
20.3.17.5. Key Developments
20.3.17.6. Sales Footprint
20.3.17.7. Strategy Overview
20.3.17.7.1. Marketing Strategy
20.3.17.7.2. Product Strategy
20.3.17.7.3. Channel Strategy
20.3.18. Braile Biomedica
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Key Financials
20.3.18.4. SWOT Analysis
20.3.18.5. Key Developments
20.3.18.6. Sales Footprint
20.3.18.7. Strategy Overview
20.3.18.7.1. Marketing Strategy
20.3.18.7.2. Product Strategy
20.3.18.7.3. Channel Strategy
20.3.18.8. Biotronik Inc Overview
20.3.18.9. Product Portfolio
20.3.18.10. Key Financials
20.3.18.11. SWOT Analysis
20.3.18.12. Key Developments
20.3.18.13. Sales Footprint
20.3.18.14. Strategy Overview
20.3.18.14.1. Marketing Strategy
20.3.18.14.2. Product Strategy
20.3.18.14.3. Channel Strategy
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 02: Global Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 03: Global Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 04: Global Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 05: Global Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 06: Global Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 07: Global Market Value (US$ Million) Analysis 2012 to 2021, By Region
Table 08: Global Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Region
Table 09: North America Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 10: North America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 11: North America Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 12: North America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 13: North America Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 14: North America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 15: North America Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 16: North America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 17: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 18: Latin America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 19: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 20: Latin America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 21: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 22: Latin America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 23: Latin America Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 24: Latin America Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 25: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 26: Europe Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 27: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 28: Europe Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 29: Europe Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 30: Europe Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 31: Europe Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 32: Europe Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 33: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 34: East Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 35: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 36: East Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 37: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 38: East Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 39: East Asia Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 40: East Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 41: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 42: South Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 43: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 44: South Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 45: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 46: South Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 47: South Asia Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 48: South Asia Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 49: Oceania Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 50: Oceania Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 51: Oceania Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 52: Oceania Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 53: Oceania Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 54: Oceania Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 55: Oceania Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 56: Oceania Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 57: Middle East and Africa (MEA) Market Value (US$ Million) Analysis 2012 to 2021, By Country
Table 58: Middle East and Africa (MEA) Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 59: Middle East and Africa (MEA) Market Value (US$ Million) Analysis 2012 to 2021, By Product
Table 60: Middle East and Africa (MEA) Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 61: Middle East and Africa (MEA) Market Value (US$ Million) Analysis 2012 to 2021, By Procedure
Table 62: Middle East and Africa (MEA) Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By Procedure
Table 63: Middle East and Africa (MEA) Market Value (US$ Million) Analysis 2012 to 2021, By End User
Table 64: Middle East and Africa (MEA) Market Value (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 02: Global Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 03: Global Market Absolute $ Opportunity, 2022 to 2032
Figure 04: Global Market Share Analysis (%), By Product, 2021 & 2032
Figure 05: Global Market Y-o-Y Analysis (%), By Product, 2022 to 2032
Figure 06: Global Market Attractiveness Analysis, By Product, 2022 to 2032
Figure 07: Global Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 08: Global Market Y-o-Y Analysis (%), By Procedure, 2022 to 2032
Figure 09: Global Market Attractiveness Analysis, By Procedure, 2022 to 2032
Figure 10: Global Market Share Analysis (%), By End User, 2021 & 2032
Figure 11: Global Market Y-o-Y Analysis (%), By End User, 2022 to 2032
Figure 12: Global Market Attractiveness Analysis, By End User, 2022 to 2032
Figure 13: Global Market Share Analysis (%), By Region, 2021 & 2032
Figure 14: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2032
Figure 15: Global Market Attractiveness Analysis, By Region, 2022 to 2032
Figure 16: North America Market Share Analysis (%), By Country (2022)
Figure 17: North America Market Share Analysis (%), By Product (2022)
Figure 18: North America Market Share Analysis (%), By Procedure (2022)
Figure 19: North America Market Share Analysis (%), By End User (2022)
Figure 20: North America Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 21: North America Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 22: North America Market Attractiveness Analysis, By Country
Figure 23: North America Market Attractiveness Analysis, By Product
Figure 24: North America Market Attractiveness Analysis, By Procedure
Figure 25: North America Market Attractiveness Analysis, By End User
Figure 26: U.S. Market Value Proportion Analysis, 2021
Figure 27: Global Vs U.S. Y-o-Y Growth Comparison, 2021 to 2032
Figure 28: U.S. Market Share Analysis (%), By Product, 2021 & 2032
Figure 29: U.S. Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 30: U.S. Market Share Analysis (%), By End User, 2021 & 2032
Figure 31: Global Vs Canada Y-o-Y Growth Comparison, 2021 to 2032
Figure 32: Canada Market Share Analysis (%), By Product, 2021 & 2032
Figure 33: Canada Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 34: Canada Market Share Analysis (%), By End User, 2021 & 2032
Figure 35: Latin America Market Share Analysis (%), By Country (2022)
Figure 36: Latin America Market Share Analysis (%), By Product (2022)
Figure 37: Latin America Market Share Analysis (%), By Procedure (2022)
Figure 38: Latin America Market Share Analysis (%), By End User (2022)
Figure 39: Latin America Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 40: Latin America Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 41: Latin America Market Attractiveness Analysis, By Country
Figure 42: Latin America Market Attractiveness Analysis, By Product
Figure 43: Latin America Market Attractiveness Analysis, By Procedure
Figure 44: Latin America Market Attractiveness Analysis, By End User
Figure 45: Brazil Market Value Proportion Analysis, 2021
Figure 46: Global Vs Brazil Y-o-Y Growth Comparison, 2021 to 2032
Figure 47: Brazil Market Share Analysis (%), By Product, 2021 & 2032
Figure 48: Brazil Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 49: Brazil Market Share Analysis (%), By End User, 2021 & 2032
Figure 50: Mexico Market Value Proportion Analysis, 2021
Figure 51: Global Vs Mexico Y-o-Y Growth Comparison, 2021 to 2032
Figure 52: Mexico Market Share Analysis (%), By Product, 2021 & 2032
Figure 53: Mexico Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 54: Mexico Market Share Analysis (%), By End User, 2021 & 2032
Figure 55: Argentina Market Value Proportion Analysis, 2021
Figure 56: Global Vs Argentina Y-o-Y Growth Comparison, 2021 to 2032
Figure 57: Argentina Market Share Analysis (%), By Product, 2021 & 2032
Figure 58: Argentina Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 59: Argentina Market Share Analysis (%), By End User, 2021 & 2032
Figure 60: Europe Market Share Analysis (%), By Country (2022)
Figure 61: Europe Market Share Analysis (%), By Product (2022)
Figure 62: Europe Market Share Analysis (%), By Procedure (2022)
Figure 63: Europe Market Share Analysis (%), By End User (2022)
Figure 64: Europe Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 65: Europe Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 66: Europe Market Attractiveness Analysis, By Country
Figure 67: Europe Market Attractiveness Analysis, By Product
Figure 68: Europe Market Attractiveness Analysis, By Procedure
Figure 69: Europe Market Attractiveness Analysis, By End User
Figure 70: U.K. Market Value Proportion Analysis, 2021
Figure 71: Global Vs U.K. Y-o-Y Growth Comparison, 2021 to 2032
Figure 72: U.K. Market Share Analysis (%), By Product, 2021 & 2032
Figure 73: U.K. Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 74: U.K. Market Share Analysis (%), By End User, 2021 & 2032
Figure 75: Germany Market Value Proportion Analysis, 2021
Figure 76: Global Vs Germany Y-o-Y Growth Comparison, 2021 to 2032
Figure 77: Germany Market Share Analysis (%), By Product, 2021 & 2032
Figure 78: Germany Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 79: Germany Market Share Analysis (%), By End User, 2021 & 2032
Figure 80: Italy Market Value Proportion Analysis, 2021
Figure 81: Global Vs Italy Y-o-Y Growth Comparison, 2021 to 2032
Figure 82: Italy Market Share Analysis (%), By Product, 2021 & 2032
Figure 83: Italy Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 84: Italy Market Share Analysis (%), By End User, 2021 & 2032
Figure 85: France Market Value Proportion Analysis, 2021
Figure 86: Global Vs France Y-o-Y Growth Comparison, 2021 to 2032
Figure 87: France Market Share Analysis (%), By Product, 2021 & 2032
Figure 88: France Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 89: France Market Share Analysis (%), By End User, 2021 & 2032
Figure 90: Spain Market Value Proportion Analysis, 2021
Figure 91: Global Vs Spain Y-o-Y Growth Comparison, 2021 to 2032
Figure 92: Spain Market Share Analysis (%), By Product, 2021 & 2032
Figure 93: Spain Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 94: Spain Market Share Analysis (%), By End User, 2021 & 2032
Figure 95: Russia Market Value Proportion Analysis, 2021
Figure 96: Global Vs Russia Y-o-Y Growth Comparison, 2021 to 2032
Figure 97: Russia Market Share Analysis (%), By Product, 2021 & 2032
Figure 98: Russia Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 99: Russia Market Share Analysis (%), By End User, 2021 & 2032
Figure 100: Nordic Countries Market Value Proportion Analysis, 2021
Figure 101: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2021 to 2032
Figure 102: Nordic Countries Market Share Analysis (%), By Product, 2021 & 2032
Figure 103: Nordic Countries Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 104: Nordic Countries Market Share Analysis (%), By End User, 2021 & 2032
Figure 105: BENELUX Market Value Proportion Analysis, 2021
Figure 106: Global Vs BENELUX Y-o-Y Growth Comparison, 2021 to 2032
Figure 107: BENELUX Market Share Analysis (%), By Product, 2021 & 2032
Figure 108: BENELUX Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 109: BENELUX Market Share Analysis (%), By End User, 2021 & 2032
Figure 110: East Asia Market Share Analysis (%), By Country (2022)
Figure 111: East Asia Market Share Analysis (%), By Product (2022)
Figure 112: East Asia Market Share Analysis (%), By Procedure (2022)
Figure 113: East Asia Market Share Analysis (%), By End User (2022)
Figure 114: East Asia Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 115: East Asia Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 116: East Asia Market Attractiveness Analysis, By Country
Figure 117: East Asia Market Attractiveness Analysis, By Product
Figure 118: East Asia Market Attractiveness Analysis, By Procedure
Figure 119: East Asia Market Attractiveness Analysis, By End User
Figure 120: China Market Value Proportion Analysis, 2021
Figure 121: Global Vs China Y-o-Y Growth Comparison, 2021 to 2032
Figure 122: China Market Share Analysis (%), By Product, 2021 & 2032
Figure 123: China Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 124: China Market Share Analysis (%), By End User, 2021 & 2032
Figure 125: Japan Market Value Proportion Analysis, 2021
Figure 126: Global Vs Japan Y-o-Y Growth Comparison, 2021 to 2032
Figure 127: Japan Market Share Analysis (%), By Product, 2021 & 2032
Figure 128: Japan Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 129: Japan Market Share Analysis (%), By End User, 2021 & 2032
Figure 130: South Korea Market Value Proportion Analysis, 2021
Figure 131: Global Vs South Korea Y-o-Y Growth Comparison, 2021 to 2032
Figure 132: South Korea Market Share Analysis (%), By Product, 2021 & 2032
Figure 133: South Korea Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 134: South Korea Market Share Analysis (%), By End User, 2021 & 2032
Figure 135: South Asia Market Share Analysis (%), By Country (2022)
Figure 136: South Asia Market Share Analysis (%), By Product (2022)
Figure 137: South Asia Market Share Analysis (%), By Procedure (2022)
Figure 138: South Asia Market Share Analysis (%), By End User (2022)
Figure 139: South Asia Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 140: South Asia Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 141: South Asia Market Attractiveness Analysis, By Country
Figure 142: South Asia Market Attractiveness Analysis, By Product
Figure 143: South Asia Market Attractiveness Analysis, By Procedure
Figure 144: South Asia Market Attractiveness Analysis, By End User
Figure 145: India Market Value Proportion Analysis, 2021
Figure 146: Global Vs India Y-o-Y Growth Comparison, 2021 to 2032
Figure 147: India Market Share Analysis (%), By Product, 2021 & 2032
Figure 148: India Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 149: India Market Share Analysis (%), By End User, 2021 & 2032
Figure 150: Thailand Market Value Proportion Analysis, 2021
Figure 151: Global Vs Thailand Y-o-Y Growth Comparison, 2021 to 2032
Figure 152: Thailand Market Share Analysis (%), By Product, 2021 & 2032
Figure 153: Thailand Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 154: Thailand Market Share Analysis (%), By End User, 2021 & 2032
Figure 155: Indonesia Market Value Proportion Analysis, 2021
Figure 156: Global Vs Indonesia Y-o-Y Growth Comparison, 2021 to 2032
Figure 157: Indonesia Market Share Analysis (%), By Product, 2021 & 2032
Figure 158: Indonesia Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 159: Indonesia Market Share Analysis (%), By End User, 2021 & 2032
Figure 160: Malaysia Market Value Proportion Analysis, 2021
Figure 161: Global Vs Malaysia Y-o-Y Growth Comparison, 2021 to 2032
Figure 162: Malaysia Market Share Analysis (%), By Product, 2021 & 2032
Figure 163: Malaysia Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 164: Malaysia Market Share Analysis (%), By End User, 2021 & 2032
Figure 165: Oceania Market Share Analysis (%), By Country (2022)
Figure 166: Oceania Market Share Analysis (%), By Product (2022)
Figure 167: Oceania Market Share Analysis (%), By Procedure (2022)
Figure 168: Oceania Market Share Analysis (%), By End User (2022)
Figure 169: Oceania Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 170: Oceania Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 171: Oceania Market Attractiveness Analysis, By Country
Figure 172: Oceania Market Attractiveness Analysis, By Product
Figure 173: Oceania Market Attractiveness Analysis, By Procedure
Figure 174: Oceania Market Attractiveness Analysis, By End User
Figure 175: Australia Market Value Proportion Analysis, 2021
Figure 176: Global Vs Australia Y-o-Y Growth Comparison, 2021 to 2032
Figure 177: Australia Market Share Analysis (%), By Product, 2021 & 2032
Figure 178: Australia Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 179: Australia Market Share Analysis (%), By End User, 2021 & 2032
Figure 180: New Zealand Market Value Proportion Analysis, 2021
Figure 181: Global Vs New Zealand Y-o-Y Growth Comparison, 2021 to 2032
Figure 182: New Zealand Market Share Analysis (%), By Product, 2021 & 2032
Figure 183: New Zealand Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 184: New Zealand Market Share Analysis (%), By End User, 2021 & 2032
Figure 185: Middle East and Africa (MEA) Market Share Analysis (%), By Country (2022)
Figure 186: Middle East and Africa (MEA) Market Share Analysis (%), By Product (2022)
Figure 187: Middle East and Africa (MEA) Market Share Analysis (%), By Procedure (2022)
Figure 188: Middle East and Africa (MEA) Market Share Analysis (%), By End User (2022)
Figure 189: Middle East and Africa (MEA) Historical Market Value (US$ Million) Analysis, 2012 to 2021
Figure 190: Middle East and Africa (MEA) Current and Future Market Value (US$ Million), 2022 to 2032 & Y-o-Y Growth Trend Analysis
Figure 191: Middle East and Africa (MEA) Market Attractiveness Analysis, By Country
Figure 192: Middle East and Africa (MEA) Market Attractiveness Analysis, By Product
Figure 193: Middle East and Africa (MEA) Market Attractiveness Analysis, By Procedure
Figure 194: Middle East and Africa (MEA) Market Attractiveness Analysis, By End User
Figure 195: Turkey Market Value Proportion Analysis, 2021
Figure 196: Global Vs Turkey Y-o-Y Growth Comparison, 2021 to 2032
Figure 197: Turkey Market Share Analysis (%), By Product, 2021 & 2032
Figure 198: Turkey Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 199: Turkey Market Share Analysis (%), By End User, 2021 & 2032
Figure 200: GCC Countries Market Value Proportion Analysis, 2021
Figure 201: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021 to 2032
Figure 202: GCC Countries Market Share Analysis (%), By Product, 2021 & 2032
Figure 203: GCC Countries Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 204: GCC Countries Market Share Analysis (%), By End User, 2021 & 2032
Figure 205: South Africa Market Value Proportion Analysis, 2021
Figure 206: Global Vs South Africa Y-o-Y Growth Comparison, 2021 to 2032
Figure 207: South Africa Market Share Analysis (%), By Product, 2021 & 2032
Figure 208: South Africa Market Share Analysis (%), By Procedure, 2021 & 2032
Figure 209: South Africa Market Share Analysis (%), By End User, 2021 & 2032
